NCT00014573View on ClinicalTrials.gov

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1998

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

autologous tumor cell vaccine

BIOLOGICAL

filgrastim

BIOLOGICAL

sargramostim

BIOLOGICAL

therapeutic autologous lymphocytes

DRUG

carmustine

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

paclitaxel

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

conventional surgery

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00014573 - Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer | Biotech Hunter | Biotech Hunter